Selection of the recommended phase 2 dose (RP2D) for subcutaneous nemvaleukin alfa: ARTISTRY-2.Omid Hamid, Marc S. Ernstoff, Ralph V. Boccia et al.|Journal of Clinical Oncology|2021Cited by 12